| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |